You are here: Home > Projects and Research lines > A phase II randomized, double-blinded, placebo-controlled study of sorafenib or placebo in combination with transarterial embolization (TACE) performed with DEB and doxorubicin for intermediate stage HCC. (SPACE)
Projects and Research lines
A phase II randomized, double-blinded, placebo-controlled study of sorafenib or placebo in combination with transarterial embolization (TACE) performed with DEB and doxorubicin for intermediate stage HCC. (SPACE)

Bayer Pharmaceuticals

Clinical research: Clinical trials in liver cancer

Liver Cancer Translational Research Laboratory

BCLC-IDIBAPS, Liver Unit, Hospital Clínic · Esther Koplowitz Center, 3rd Floor
Rosselló 153 · 08036 Barcelona · Tel: +34 93 227 9155

© Liver Cancer Translational Research Laboratory - IDIBAPS 2011 - 2017